Rezultati pretrage - Vicky Roy

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination od Vicky Roy, Wonyeong Jung, Caitlyn Linde, Emily Coates, Julie Ledgerwood, Pamela Costner, Galina Yamshchikov, Hendrik Streeck, Boris Juelg, Douglas A. Lauffenburger, Galit Alter

Preuzmi cijeli tekst

Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease od Antonio G. Dias, Jr., Elias M. Duarte, Jose Victor Zambrana, Jaime A. Cardona-Ospina, Sandra Bos, Vicky Roy, Julia Huffaker, Guillermina Kuan, Angel Balmaseda, Galit Alter, Eva Harris

Preuzmi cijeli tekst

Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infection od Shlomi Ilan, Yannic Bartsch, Wonyeong Jung, Evgenii Kliuchnikov, Vicky Roy, Riley Bonifer, Victoria E. K. Walker-Sperling, Erica N. Borducchi, Joseph P. Nkolola, Douglas A. Lauffenburger, Daniel J. Stieh, Dan H. Barouch, Boris Julg

Preuzmi cijeli tekst

Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern od Ryan P. McNamara, Jenny S. Maron, Julie Boucau, Vicky Roy, Nicholas E. Webb, Harry L. Bertera, Amy K. Barczak, The Positives Study Staff, Nicholas Franko, Jennifer K. Logue, Megan Kemp, Jonathan Z. Li, Ling Zhou, Ching-Lin Hsieh, Jason S. McLellan, Mark J. Siedner, Michael S. Seaman, Jacob E. Lemieux, Helen Y. Chu, Galit Alter

Preuzmi cijeli tekst

Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 od Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, Sebastian Ols, Daniel J. Sheward, Changil Kim, Alberto Cagigi, Matthew Gagne, Brandon Davis, Daritza Germosen, Vicky Roy, Galit Alter, Hélène Letscher, Jérôme Van Wassenhove, Wesley Gros, Anne-Sophie Gallouët, Roger Le Grand, Harry Kleanthous, Mimi Guebre-Xabier, Ben Murrell, Nita Patel, Gregory Glenn, Gale Smith, Karin Loré

Preuzmi cijeli tekst

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsResearch in context od Christopher L. Cooper, Gavin Morrow, Maoli Yuan, Thomas S. Postler, Maxwell L. Neal, Robert W. Cross, Courtney Woolsey, Krystle N. Agans, Viktoriya Borisevich, Ryan P. McNamara, Caroline Atyeo, Vicky Roy, Daritza Germosen, Fuxiang Hou, Shui L. Li, Lucia Reiserova, Yesle Choi, Aaron Wilson, Denise Wagner, Olivia Wallace-Selman, Alexei Carpov, Fuqiang Geng, Deborah J. Frederick, Joanne DeStefano, Anne M. Ercolini, Adrian S. Enriquez, Kathryn M. Hastie, Suzane Ramos da Silva, Eddy Sayeed, John W. Coleman, Andrew Kilianski, Galit Alter, Erica Ollmann Saphire, John D. Aitchison, Thomas W. Geisbert, Swati B. Gupta, Mark B. Feinberg, Christopher L. Parks

Preuzmi cijeli tekst